Drug Shortage Report for RELEFACT TRH INJECTION 200MCG/ML

Last updated on 2017-10-05 History
Report ID 949
Drug Identification Number 02224615
Brand name RELEFACT TRH INJECTION 200MCG/ML
Common or Proper name Protirelin Injection i.v.
Company Name ODAN LABORATORIES LTD
Market Status DORMANT
Active Ingredient(s) Protirelin
Strength(s) 0.2 mg/mL
Dosage form(s) Liquid
Route of administration I.V. injection
Packaging size 1 mL
ATC code V04CJ
ATC description OTHER DIAGNOSTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-04-15
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments
Health Canada comments
Tier 3 Status No
Company contact information info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 2 of 2